8. Preventing Sudden Cardiac Arrest in the Heart Failure Patient

  1. Barry H. Greenberg1,
  2. Denise D. Barnard1,
  3. Sanjiv M. Narayan2,
  4. John R. Teerlink3,4
  1. Sanjiv M. Narayan MB, MD, FRCP, FACC

Published Online: 14 SEP 2010

DOI: 10.1002/9780470669402.ch8

Book Title

Management of Heart Failure

Management of Heart Failure

Additional Information

How to Cite

Narayan, S. M. (2010) Preventing Sudden Cardiac Arrest in the Heart Failure Patient, in Management of Heart Failure (eds B. H. Greenberg, D. D. Barnard, S. M. Narayan and J. R. Teerlink), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470669402.ch8

Editor Information

  1. 1

    Division of Cardiology, University of California, San Diego, California, USA

  2. 2

    University of California and Veterans Affairs Medical Center, San Diego, California, USA

  3. 3

    Section of Cardiology, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA

  4. 4

    School of Medicine, University of California, San Francisco, California, USA

Author Information

  1. University of California and Veterans Affairs Medical Center, San Diego, California, USA

Publication History

  1. Published Online: 14 SEP 2010
  2. Published Print: 8 OCT 2010

ISBN Information

Print ISBN: 9780470753798

Online ISBN: 9780470669402

SEARCH

CHAPTER TOOLS

Get PDF (1107K)

Keywords:

  • devices, and anti-arrhythmic therapy of heart failure;
  • sudden cardiac arrest prevention - in heart failure patient;
  • sudden cardiac arrest (SCA) from ventricular arrhythmias - largest cause of death in industrialized countries;
  • pharmacologic therapy - foundation for managing systolic heart failure;
  • implantable cardioverter defibrillator (ICD) - reducing mortality from SCA in patients with systolic heart failure;
  • ‘traditional’ antiarrhythmic drugs - less compelling data than other agents in preventing SCA;
  • Guideline-Based Flowchart for ICD therapy - in heart failure patients;
  • clinical risk scores, improving risk stratification for SCA;
  • heart rate turbulence (HRT) - quantifying post-PVC changes in sinus rate;
  • substantial peri-infarct zone - and cardiac MRI predicting mortality

Summary

This chapter contains sections titled:

  • Introduction

  • Pharmacologic therapies to prevent SCA in heart failure

  • Which heart failure patients benefit from the ICD?

  • The clinical dilemma: How to use the guidelines

  • Clinical risk scores may improve risk stratification for SCA

  • Emerging technologies to improve the risk stratification for SCA

  • Conclusions

  • Acknowledgements

  • References

Get PDF (1107K)